Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gain Therapeutics (GANX) Current Leases (2020 - 2025)

Gain Therapeutics (GANX) has 6 years of Current Leases data on record, last reported at $115910.0 in Q3 2025.

  • For Q3 2025, Current Leases fell 35.17% year-over-year to $115910.0; the TTM value through Sep 2025 reached $115910.0, down 35.17%, while the annual FY2024 figure was $160913.0, 29.94% down from the prior year.
  • Current Leases reached $115910.0 in Q3 2025 per GANX's latest filing, down from $136320.0 in the prior quarter.
  • Across five years, Current Leases topped out at $235798.0 in Q2 2023 and bottomed at $115910.0 in Q3 2025.
  • Average Current Leases over 5 years is $191368.7, with a median of $204569.0 recorded in 2024.
  • Peak YoY movement for Current Leases: soared 83.22% in 2022, then tumbled 35.17% in 2025.
  • A 5-year view of Current Leases shows it stood at $219137.0 in 2021, then rose by 4.54% to $229080.0 in 2022, then increased by 0.27% to $229693.0 in 2023, then decreased by 29.94% to $160913.0 in 2024, then decreased by 27.97% to $115910.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Current Leases were $115910.0 in Q3 2025, $136320.0 in Q2 2025, and $148674.0 in Q1 2025.